Cheng Li's Stock Ratings

Oppenheimer Analyst

Cheng Li is an analyst at Oppenheimer. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/15/2025

Updated: Dec 15, 2025

Overall Average Return

33.8%

Smart Score

54.1%

Overall Average Return Percentile

88th

Number of Ratings

3
Buy NowGet Alert
12/16/2025WVEBuy Now
WAVE Life Sciences
$16.1897.78%$24 → $32MaintainsOutperformGet Alert
07/28/2025WVEBuy Now
WAVE Life Sciences
$16.1848.33% → $24Initiates → OutperformGet Alert
08/15/2024VXRTBuy Now
Vaxart
$0.361009.02% → $4Initiates → OutperformGet Alert

Recent Analyst Stock Rating News

What's Going On With Canaan Stock Today?
What's Going On With Canaan Stock Today?
Shares of Canaan are trading higher Tuesday after the crypto mining company reported better-than-expected unaudited third-quarter earnings.
What 21 Analyst Ratings Have To Say About Intellia Therapeutics
What 21 Analyst Ratings Have To Say About Intellia Therapeutics
Delek US Holdings Analysts Boost Their Forecasts After Q3 Results
Delek US Holdings Analysts Boost Their Forecasts After Q3 Results
Deep Dive Into WAVE Life Sciences Stock: Analyst Perspectives (6 Ratings)
Demystifying EOG Resources: Insights From 13 Analyst Reviews
Marathon Petroleum Stock: A Deep Dive Into Analyst Perspectives (12 Ratings)
11 Analysts Assess PBF Energy: What You Need To Know
Expert Outlook: APA Through The Eyes Of 17 Analysts
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free
Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2025 Benzinga | All Rights Reserved